429 related articles for article (PubMed ID: 25985292)
1. Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant α-Synuclein.
Ahsan N; Mishra S; Jain MK; Surolia A; Gupta S
Sci Rep; 2015 May; 5():9862. PubMed ID: 25985292
[TBL] [Abstract][Full Text] [Related]
2. A routinely used protein staining dye acts as an inhibitor of wild type and mutant alpha-synuclein aggregation and modulator of neurotoxicity.
Ahsan N; Siddique IA; Gupta S; Surolia A
Eur J Med Chem; 2018 Jan; 143():1174-1184. PubMed ID: 29150334
[TBL] [Abstract][Full Text] [Related]
3. Effect of curcumin analogs onα-synuclein aggregation and cytotoxicity.
Jha NN; Ghosh D; Das S; Anoop A; Jacob RS; Singh PK; Ayyagari N; Namboothiri IN; Maji SK
Sci Rep; 2016 Jun; 6():28511. PubMed ID: 27338805
[TBL] [Abstract][Full Text] [Related]
4. Curcumin-glucoside, a novel synthetic derivative of curcumin, inhibits α-synuclein oligomer formation: relevance to Parkinson's disease.
Gadad BS; Subramanya PK; Pullabhatla S; Shantharam IS; Rao KS
Curr Pharm Des; 2012; 18(1):76-84. PubMed ID: 22211690
[TBL] [Abstract][Full Text] [Related]
5. Seeking a mechanism for the toxicity of oligomeric α-synuclein.
Roberts HL; Brown DR
Biomolecules; 2015 Mar; 5(2):282-305. PubMed ID: 25816357
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of Cu
Lorentzon E; Kumar R; Horvath I; Wittung-Stafshede P
Biometals; 2020 Jun; 33(2-3):97-106. PubMed ID: 32170541
[TBL] [Abstract][Full Text] [Related]
7. Curcumin inhibits aggregation of alpha-synuclein.
Pandey N; Strider J; Nolan WC; Yan SX; Galvin JE
Acta Neuropathol; 2008 Apr; 115(4):479-89. PubMed ID: 18189141
[TBL] [Abstract][Full Text] [Related]
8. Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons.
Colla E; Panattoni G; Ricci A; Rizzi C; Rota L; Carucci N; Valvano V; Gobbo F; Capsoni S; Lee MK; Cattaneo A
Neurobiol Dis; 2018 Mar; 111():36-47. PubMed ID: 29246724
[TBL] [Abstract][Full Text] [Related]
9. A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity.
Perni M; Galvagnion C; Maltsev A; Meisl G; Müller MB; Challa PK; Kirkegaard JB; Flagmeier P; Cohen SI; Cascella R; Chen SW; Limbocker R; Sormanni P; Heller GT; Aprile FA; Cremades N; Cecchi C; Chiti F; Nollen EA; Knowles TP; Vendruscolo M; Bax A; Zasloff M; Dobson CM
Proc Natl Acad Sci U S A; 2017 Feb; 114(6):E1009-E1017. PubMed ID: 28096355
[TBL] [Abstract][Full Text] [Related]
10. Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism.
Liu Z; Yu Y; Li X; Ross CA; Smith WW
Pharmacol Res; 2011 May; 63(5):439-44. PubMed ID: 21237271
[TBL] [Abstract][Full Text] [Related]
11. Polyphenols in combination with β-cyclodextrin can inhibit and disaggregate α-synuclein amyloids under cell mimicking conditions: A promising therapeutic alternative.
Gautam S; Karmakar S; Batra R; Sharma P; Pradhan P; Singh J; Kundu B; Chowdhury PK
Biochim Biophys Acta Proteins Proteom; 2017 May; 1865(5):589-603. PubMed ID: 28238838
[TBL] [Abstract][Full Text] [Related]
12. Role of Sporadic Parkinson Disease Associated Mutations A18T and A29S in Enhanced α-Synuclein Fibrillation and Cytotoxicity.
Kumar S; Jangir DK; Kumar R; Kumari M; Bhavesh NS; Maiti TK
ACS Chem Neurosci; 2018 Feb; 9(2):230-240. PubMed ID: 28841377
[TBL] [Abstract][Full Text] [Related]
13. DEAD-box RNA helicase Dbp4/DDX10 is an enhancer of α-synuclein toxicity and oligomerization.
Popova B; Wang D; Pätz C; Akkermann D; Lázaro DF; Galka D; Kolog Gulko M; Bohnsack MT; Möbius W; Bohnsack KE; Outeiro TF; Braus GH
PLoS Genet; 2021 Mar; 17(3):e1009407. PubMed ID: 33657088
[TBL] [Abstract][Full Text] [Related]
14. Scutellarin inhibits the uninduced and metal-induced aggregation of α-Synuclein and disaggregates preformed fibrils: implications for Parkinson's disease.
Zaidi FK; Deep S
Biochem J; 2020 Feb; 477(3):645-670. PubMed ID: 31939603
[TBL] [Abstract][Full Text] [Related]
15. Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies.
Villar-Piqué A; Lopes da Fonseca T; Outeiro TF
J Neurochem; 2016 Oct; 139 Suppl 1():240-255. PubMed ID: 26190401
[TBL] [Abstract][Full Text] [Related]
16. Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution.
Li X; Dong C; Hoffmann M; Garen CR; Cortez LM; Petersen NO; Woodside MT
Sci Rep; 2019 Feb; 9(1):1734. PubMed ID: 30741954
[TBL] [Abstract][Full Text] [Related]
17. Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form.
Collier TJ; Srivastava KR; Justman C; Grammatopoulous T; Hutter-Paier B; Prokesch M; Havas D; Rochet JC; Liu F; Jock K; de Oliveira P; Stirtz GL; Dettmer U; Sortwell CE; Feany MB; Lansbury P; Lapidus L; Paumier KL
Neurobiol Dis; 2017 Oct; 106():191-204. PubMed ID: 28711409
[TBL] [Abstract][Full Text] [Related]
18. Synaptic vesicle mimics affect the aggregation of wild-type and A53T α-synuclein variants differently albeit similar membrane affinity.
Rocha S; Kumar R; Horvath I; Wittung-Stafshede P
Protein Eng Des Sel; 2019 Dec; 32(2):59-66. PubMed ID: 31566224
[TBL] [Abstract][Full Text] [Related]
19. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
[TBL] [Abstract][Full Text] [Related]
20. The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity.
Xu CK; Castellana-Cruz M; Chen SW; Du Z; Meisl G; Levin A; Mannini B; Itzhaki LS; Knowles TPJ; Dobson CM; Cremades N; Kumita JR
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
